Polar Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | $19M | Sell |
250,000
-255,000
| -50% | -$19.4M | 0.14% | 137 |
|
2020
Q2 | $62.3M | Buy |
505,000
+305,000
| +153% | +$37.6M | 0.54% | 57 |
|
2020
Q1 | $16.9M | Buy |
200,000
+80,000
| +67% | +$6.76M | 0.18% | 139 |
|
2019
Q4 | $10.1M | Sell |
120,000
-5,000
| -4% | -$423K | 0.09% | 199 |
|
2019
Q3 | $8.43M | Buy |
125,000
+10,000
| +9% | +$674K | 0.08% | 209 |
|
2019
Q2 | $9.85M | Hold |
115,000
| – | – | 0.09% | 192 |
|
2019
Q1 | $10.2M | Sell |
115,000
-39,370
| -26% | -$3.5M | 0.09% | 181 |
|
2018
Q4 | $13.1M | Hold |
154,370
| – | – | 0.14% | 156 |
|
2018
Q3 | $15M | Sell |
154,370
-57,130
| -27% | -$5.54M | 0.13% | 164 |
|
2018
Q2 | $19.9K | Sell |
211,500
-800
| -0.4% | -$75 | 0.12% | 155 |
|
2018
Q1 | $17.2M | Sell |
212,300
-42,500
| -17% | -$3.45M | 0.17% | 148 |
|
2017
Q4 | $22.7M | Sell |
254,800
-11,911
| -4% | -$1.06M | 0.23% | 122 |
|
2017
Q3 | $24.8M | Buy |
266,711
+22,500
| +9% | +$2.09M | 0.28% | 111 |
|
2017
Q2 | $22.2M | Sell |
244,211
-238,089
| -49% | -$21.6M | 0.3% | 112 |
|
2017
Q1 | $42.3M | Buy |
482,300
+67,800
| +16% | +$5.95M | 0.63% | 47 |
|
2016
Q4 | $34.3M | Buy |
414,500
+145,000
| +54% | +$12M | 0.55% | 47 |
|
2016
Q3 | $24.9M | Sell |
269,500
-32,155
| -11% | -$2.97M | 0.43% | 70 |
|
2016
Q2 | $23.5M | Sell |
301,655
-49,527
| -14% | -$3.85M | 0.44% | 72 |
|
2016
Q1 | $29M | Buy |
351,182
+325,460
| +1,265% | +$26.8M | 0.54% | 51 |
|
2015
Q4 | $2.7M | Buy |
25,722
+13,603
| +112% | +$1.43M | 0.05% | 203 |
|
2015
Q3 | $1.28M | Buy |
12,119
+216
| +2% | +$22.7K | 0.03% | 237 |
|
2015
Q2 | $1.63M | Buy |
11,903
+1,940
| +19% | +$265K | 0.03% | 235 |
|
2015
Q1 | $1.24M | Buy |
9,963
+2,088
| +27% | +$260K | 0.02% | 245 |
|
2014
Q4 | $712K | Buy |
7,875
+3,910
| +99% | +$354K | 0.01% | 247 |
|
2014
Q3 | $286K | Sell |
3,965
-2,299
| -37% | -$166K | 0.01% | 259 |
|
2014
Q2 | $390K | Buy |
+6,264
| New | +$390K | 0.01% | 252 |
|